Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer–a systematic review and meta-analysis
MET exon 14 mutation is an uncommon genomic alteration in non-small cell lung cancer
(NSCLC). This meta-analysis aimed at investigating the clinicopathological and prognostic …
(NSCLC). This meta-analysis aimed at investigating the clinicopathological and prognostic …
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach
M Volante, P Collini, YE Nikiforov… - The American journal …, 2007 - journals.lww.com
Poorly differentiated (PD) thyroid carcinomas lie both morphologically and behaviorally
between well-differentiated and undifferentiated (anaplastic) carcinomas. Following the …
between well-differentiated and undifferentiated (anaplastic) carcinomas. Following the …
[HTML][HTML] The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review
Background The genetic alterations of papillary thyroid carcinoma (PTC) have been
reported to change over the past few decades. We performed this systematic review to …
reported to change over the past few decades. We performed this systematic review to …
Pendrin, the Protein Encoded by the Pendred Syndrome Gene (PDS), Is an Apical Porter of Iodide in the Thyroid and Is Regulated by Thyroglobulin in FRTL-5 Cells
IE Royaux, K Suzuki, A Mori, R Katoh, LA Everett… - …, 2000 - academic.oup.com
Pendred syndrome is an autosomal recessive disorder characterized by congenital
deafness and thyroid goiter. The thyroid disease typically develops around puberty and is …
deafness and thyroid goiter. The thyroid disease typically develops around puberty and is …
Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis
Objective Diffuse sclerosing variant papillary thyroid carcinoma (DSVPTC) is an uncommon
variant of papillary thyroid carcinoma (PTC). The biological behaviors and prognostic …
variant of papillary thyroid carcinoma (PTC). The biological behaviors and prognostic …
Observer variation of encapsulated follicular lesions of the thyroid gland
M Hirokawa, JA Carney, JR Goellner… - The American journal …, 2002 - journals.lww.com
Although histologic definition of follicular thyroid lesions is readily available, application of
the diagnostic criteria and personal experience may lead to disagreement among …
the diagnostic criteria and personal experience may lead to disagreement among …
Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials
DF Ma, LQ Qin, PY Wang, R Katoh - Clinical nutrition, 2008 - Elsevier
BACKGROUND & AIMS: The effects of isoflavones on bone loss appear inconsistent in
randomized controlled trials. Therefore, we used a statistical method of combining these …
randomized controlled trials. Therefore, we used a statistical method of combining these …
Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients
R Katoh, J Sasaki, H Kurihara, K Suzuki, Y Iida… - Cancer, 1992 - Wiley Online Library
Multiple thyroid involvement (MTI) in papillary thyroid carcinoma was clinicopathologically
studied in 105 non‐selected, consecutive patients. Whole thyroids resected by total …
studied in 105 non‐selected, consecutive patients. Whole thyroids resected by total …
Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated β-cell failure in fulminant type 1 diabetes
S Tanaka, Y Nishida, K Aida, T Maruyama… - Diabetes, 2009 - Am Diabetes Assoc
OBJECTIVE Fulminant type 1 diabetes is characterized by the rapid onset of severe
hyperglycemia and ketoacidosis, with subsequent poor prognosis of diabetes complications …
hyperglycemia and ketoacidosis, with subsequent poor prognosis of diabetes complications …
[HTML][HTML] Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms
H Ishii, M Saitoh, K Sakamoto, T Kondo, R Katoh… - Journal of Biological …, 2014 - ASBMB
ESRP1 (epithelial splicing regulatory protein 1) and ESRP2 regulate alternative splicing
events associated with epithelial phenotypes of cells, and both are down-regulated during …
events associated with epithelial phenotypes of cells, and both are down-regulated during …